Benzidine
|
WikiDoc Resources for Benzidine |
|
Articles |
|---|
|
Most recent articles on Benzidine |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Benzidine at Clinical Trials.gov Clinical Trials on Benzidine at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Benzidine
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Benzidine Discussion groups on Benzidine Directions to Hospitals Treating Benzidine Risk calculators and risk factors for Benzidine
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Benzidine |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
Benzidine is the trivial name for 4,4'-diaminobiphenyl, a carcinogenic aromatic amine which has been used as part of a test for cyanide and also in the synthesis of dyes. It has been linked to bladder cancer and pancreatic cancer.
In common with benzidine some other aromatic amines such as 2-aminonaphthalene have been withdrawn from use in almost all industries because they are so carcinogenic.
In the past a common test for blood used benzidine but this has largely been replaced by tests using phenolphthalein / hydrogen peroxide and luminol. An enzyme in blood causes the benzidine to be oxidized to a polymer which is blue coloured. The test for cyanide uses similar chemistry to give the blue colour.
Benzidine is a known human carcinogen. [1]
Benzidine rearrangement
In a classic rearrangement reaction called the benzidine rearrangement benzidine is formed by reaction of the 1,2-diphenylhydrazine (PhNHNHPh) with acids. One plausible reaction mechanism has both hydrazine nitrogen atoms protonated after which a sigmatropic reaction takes place [2].